118 related articles for article (PubMed ID: 785150)
1. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
Fidetzis K; Brosteano R; Keller P
Med Welt; 1976 Jul; 27(29):1412-4. PubMed ID: 785150
[No Abstract] [Full Text] [Related]
2. [The treatment of ischemic cerebral accidents with pervincamine].
Warot P; Caron JC
Lille Med; 1971 Apr; 16():S 2:6l4-9. PubMed ID: 5162101
[No Abstract] [Full Text] [Related]
3. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
Kauchtschischvili G; Nappi G; Bono G
Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
[No Abstract] [Full Text] [Related]
4. [Strong delayed-action pervincamine in general medicine].
Warembourg H; Ketelers JY
Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
De Pergola E; Di Lorenzo L; De Pergola G
G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
[No Abstract] [Full Text] [Related]
6. [Angiographic study of the action of pervincamine on cerebral circulation].
Baiano G; Elefante R; Granata F; Graziussi G
Acta Neurol (Napoli); 1974 Mar; 29(2):185-9. PubMed ID: 4848048
[No Abstract] [Full Text] [Related]
7. Open-labeled phase III clinical trials with vinpocetine in Japan.
Ebi O
Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
[No Abstract] [Full Text] [Related]
8. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
Periti P; Periti G; Colombo Pirola L
Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
[No Abstract] [Full Text] [Related]
9. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
Riccardi T; Passeri F; Locatelli F
Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
[TBL] [Abstract][Full Text] [Related]
10. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
Franzini C; Ferrante P
Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
[No Abstract] [Full Text] [Related]
11. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
Holemans P
Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
Desruelles J; Camart JF
LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
[No Abstract] [Full Text] [Related]
13. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
[TBL] [Abstract][Full Text] [Related]
14. [Controlled multicenter clinical studies on the effect of (-)eburnamonine versus placebo in patients with chronic senile cerebral insufficiency of medium significance].
Aveni-Casucci MA; Canal N; Corsico R; Passeri M; Porro A; Ventura A
G Clin Med; 1983; 64(9-10):372-94. PubMed ID: 6363189
[No Abstract] [Full Text] [Related]
15. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Tamaki N; Kusunoki T; Matsumoto S
Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
[No Abstract] [Full Text] [Related]
16. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
Sov Med; 1983; (10):111-3. PubMed ID: 6658534
[No Abstract] [Full Text] [Related]
17. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
Bargheon J; Durocher AM; Lagrange M
Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
Schenker H
Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
[No Abstract] [Full Text] [Related]
19. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
Witzmann HK; Blechacz W
Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
[No Abstract] [Full Text] [Related]
20. [About cavinton therapy of the patients with brain vascular diseases].
Nikitina VV; Pravdina AN; Zapatrina OV
Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
